{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:58:48Z","timestamp":1787313528293,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T00:00:00Z","timestamp":1755475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ajogmf.2025.101768","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T17:20:48Z","timestamp":1755624048000},"page":"101768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Maternal, fetal, and neonatal serious adverse events associated with low-dose aspirin during the first trimester of pregnancy: A secondary analysis of the Aspirin Supplmentation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) trial"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4306-7195","authenticated-orcid":false,"given":"Maria J.","family":"Rodriguez-Sibaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Galvez-Rubalcava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Hagerman-Sucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Alcocer-Gonzalez Camarena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan R.","family":"Gomez-Woodworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara I.","family":"Villalpando-Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Acevedo-Gallegos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Velazquez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Ramirez-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Yazmin","family":"Copado-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5378-5724","authenticated-orcid":false,"given":"Mario I.","family":"Lumbreras-Marquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajogmf.2025.101768_bib0001","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ajogmf.2025.101768_bib0002","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101768_bib0003","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/AOG.0000000000002709","article-title":"ACOG committee opinion No. 743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.ajogmf.2025.101768_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet Off organ Int Fed Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101768_bib0005","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/1471-0528.15386","article-title":"Care of women with obesity in pregnancy: green-top guideline No. 72","volume":"126","author":"Denison","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.ajogmf.2025.101768_bib0006","first-page":"439","article-title":"WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia","volume":"97","author":"Sammour","year":"2011","journal-title":"WHO Recomm Prev Treat Pre-Eclampsia Eclampsia"},{"issue":"12","key":"10.1016\/j.ajogmf.2025.101768_bib0007","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101768_bib0008","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1097\/AOG.0000000000005517","article-title":"Aspirin in pregnancy","volume":"143","author":"Hoffman","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ajogmf.2025.101768_bib0009","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/AOG.0000000000005429","article-title":"Aspirin in Pregnancy","volume":"142","author":"Jones Pullins","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"2S","key":"10.1016\/j.ajogmf.2025.101768_bib0010","doi-asserted-by":"crossref","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","article-title":"Prevention of preeclampsia with aspirin","volume":"226","author":"Rolnik","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ajogmf.2025.101768_bib0011","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ajog.2023.04.031","article-title":"Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations?","volume":"229","author":"Horgan","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101768_bib0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00404-007-0527-x","article-title":"Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study","volume":"278","author":"Fawzy","year":"2008","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101768_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004734.pub3","article-title":"Aspirin or anticoagulants for treating recurrent miscarriage in women without antiphospholipid syndrome","author":"Kaandorp","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.ajogmf.2025.101768_bib0014","article-title":"Aspirin for in vitro fertilisation","volume":"11","author":"Siristatidis","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101768_bib0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/GCO.0b013e32832a0673","article-title":"Effects of low-dose aspirin in in-vitro fertilization","volume":"21","author":"Schisterman","year":"2009","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ajogmf.2025.101768_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13378","article-title":"Inherited thrombophilia and anticoagulant therapy for women with reproductive failure","volume":"85","author":"Han","year":"2021","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101768_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11030675","article-title":"Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review","volume":"11","author":"Alijotas-Reig","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ajogmf.2025.101768_bib0018","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/uog.20859","article-title":"Impact of low-dose aspirin on adverse perinatal outcome: meta-analysis and meta-regression","volume":"55","author":"Turner","year":"2020","journal-title":"Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ajogmf.2025.101768_bib0019","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.08.047","article-title":"Does low-dose aspirin initiated before 11 weeks\u2019 gestation reduce the rate of preeclampsia?","volume":"222","author":"Chaemsaithong","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ajogmf.2025.101768_bib0020","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","volume":"2019","author":"Duley","year":"2019","journal-title":"Cochrane database Syst Rev"},{"issue":"9575","key":"10.1016\/j.ajogmf.2025.101768_bib0021","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101768_bib0022","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/1099-1557(200005\/06)9:3<193::AID-PDS498>3.0.CO;2-I","article-title":"A population-based case-control teratologic study of acetylsalicylic acid treatments during pregnancy","volume":"9","author":"Czeizel","year":"2000","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101768_bib0023","article-title":"Safety of daily low-dose aspirin use during pregnancy in low-income and middle-income countries","volume":"1","author":"Short","year":"2021","journal-title":"AJOG Glob Rep"},{"issue":"10220","key":"10.1016\/j.ajogmf.2025.101768_bib0024","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101768_bib0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12884-017-1312-x","article-title":"A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study","volume":"17","author":"Hoffman","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"9946","key":"10.1016\/j.ajogmf.2025.101768_bib0026","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","article-title":"International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project","volume":"384","author":"Villar","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ajogmf.2025.101768_bib0027","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1067\/mob.2002.127376","article-title":"Aspirin consumption during the first trimester of pregnancy and congenital anomalies: a meta-analysis","volume":"187","author":"Kozer","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101768_bib0028","doi-asserted-by":"crossref","first-page":"95.e1","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","volume":"224","author":"Hastie","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ajogmf.2025.101768_bib0029","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ijgo.14334","article-title":"Low-dose aspirin use in the first trimester of pregnancy and odds of congenital anomalies: A meta-analysis of randomized controlled trials","volume":"160","author":"Garza-Galvan","year":"2023","journal-title":"Int J Gynaecol Obstet Off organ Int Fed Gynaecol Obstet"},{"issue":"3","key":"10.1016\/j.ajogmf.2025.101768_bib0030","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ajog.2004.10.598","article-title":"Aspirin use during early pregnancy and the risk of congenital abnormalities: a population-based case-control study","volume":"192","author":"N\u00f8rg\u00e5rd","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ajogmf.2025.101768_bib0031","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ajogmf.2025.101768_bib0032","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/uog.19077","article-title":"Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ajogmf.2025.101768_bib0033","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-0528.1995.tb10872.x","article-title":"Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group","volume":"102","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"issue":"12","key":"10.1016\/j.ajogmf.2025.101768_bib0034","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/1471-0528.17871","article-title":"In utero aspirin exposure and child neurocognitive development: a propensity score-matched analysis","volume":"131","author":"Zhu","year":"2024","journal-title":"BJOG"}],"container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933325001673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933325001673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:00:29Z","timestamp":1780120829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933325001673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2589933325001673"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2025.101768","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal, fetal, and neonatal serious adverse events associated with low-dose aspirin during the first trimester of pregnancy: A secondary analysis of the Aspirin Supplmentation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN) trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2025.101768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101768"}}